Rosini S - Search Results

1

Role of the Osteochondral Unit in the Pathogenesis of Osteoarthritis: Focus on the Potential Use of Clodronate.

Molfetta L, Casabella A, Rosini S, Saviola G, Palermo A. Molfetta L, et al. Among authors: rosini s. Curr Rheumatol Rev. 2022;18(1):2-11. doi: 10.2174/1573397117666211006094117. Curr Rheumatol Rev. 2022. PMID: 34615451 Review.

2

Effects of clodronate on synovial fluid levels of some inflammatory mediators, after intra-articular administration to patients with synovitis secondary to knee osteoarthritis.

Cocco R, Tofi C, Fioravanti A, Nerucci F, Nannipieri F, Zampieri A, Rosini S, Marcolongo R. Cocco R, et al. Among authors: rosini s. Boll Soc Ital Biol Sper. 1999 Nov-Dec;75(11-12):71-6. Boll Soc Ital Biol Sper. 1999. PMID: 11433681 Clinical Trial.

3

Osteogenic growth peptide effects on primary human osteoblast cultures: potential relevance for the treatment of glucocorticoid-induced osteoporosis.

Spreafico A, Frediani B, Capperucci C, Leonini A, Gambera D, Ferrata P, Rosini S, Di Stefano A, Galeazzi M, Marcolongo R. Spreafico A, et al. Among authors: rosini s. J Cell Biochem. 2006 Jul 1;98(4):1007-20. doi: 10.1002/jcb.20836. J Cell Biochem. 2006. PMID: 16795077

4

[Diacetylrhein in the treatment of degenerative arthropathies].

Adami S, Bortolotti R, Guarrera G, Marini G, Rosini S, Zampieri A, Lo Cascio V. Adami S, et al. Among authors: rosini s. Clin Ter. 1985 Mar 15;112(5):439-43. Clin Ter. 1985. PMID: 4017469 Italian. No abstract available.

5

Sequential treatment of Paget's disease with human calcitonin and dichloromethylene diphosphonate (Cl2MDP).

Adami S, Guarrera G, Salvagno G, Spiazzi G, Marini G, Rosini S, Lo Cascio V. Adami S, et al. Among authors: rosini s. Metab Bone Dis Relat Res. 1984;5(6):265-7. doi: 10.1016/0221-8747(84)90012-2. Metab Bone Dis Relat Res. 1984. PMID: 6238218

6

Treatment of Paget's disease of bone with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate.

Adami S, Salvagno G, Guarrera G, Montesanti F, Garavelli S, Rosini S, Lo Cascio V. Adami S, et al. Among authors: rosini s. Calcif Tissue Int. 1986 Oct;39(4):226-9. doi: 10.1007/BF02555208. Calcif Tissue Int. 1986. PMID: 2947663

7

Dichloromethylene-diphosphonate in patients with prostatic carcinoma metastatic to the skeleton.

Adami S, Salvagno G, Guarrera G, Bianchi G, Dorizzi R, Rosini S, Mobilio G, Lo Cascio V. Adami S, et al. Among authors: rosini s. J Urol. 1985 Dec;134(6):1152-4. doi: 10.1016/s0022-5347(17)47663-4. J Urol. 1985. PMID: 2932559

8

Understanding bisphosphonates and osteonecrosis of the jaw: uses and risks.

Rosini S, Rosini S, Bertoldi I, Frediani B. Rosini S, et al. Eur Rev Med Pharmacol Sci. 2015 Sep;19(17):3309-17. Eur Rev Med Pharmacol Sci. 2015. PMID: 26400539 Free article. Review.

9

The acute-phase response after bisphosphonate administration.

Adami S, Bhalla AK, Dorizzi R, Montesanti F, Rosini S, Salvagno G, Lo Cascio V. Adami S, et al. Among authors: rosini s. Calcif Tissue Int. 1987 Dec;41(6):326-31. doi: 10.1007/BF02556671. Calcif Tissue Int. 1987. PMID: 3124942

10

Use of dichloromethylene diphosphonate in metastatic bone disease.

Jung A, van Ouwenaller C, Chantraine A, Donath A, Rosini S. Jung A, et al. Among authors: rosini s. N Engl J Med. 1981 Aug 6;305(6):343-4. doi: 10.1056/NEJM198108063050612. N Engl J Med. 1981. PMID: 6454076 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

116 results

Search Page